United States News Todas as matérias

Oil prices rose more than 3% on Wednesday after U.S. strikes on Iran following attacks on three ships in the Strait of Hormuz increased concerns about the stability of energy supplies.

Vera Therapeutics (NASDAQ:VERA) received United States FDA accelerated approval for TRUTAKNA (atacicept-vymj) to reduce proteinuria in adults with primary IgA nephropathy at risk of rapid disease progression.

SkinHealth Systems (NASDAQ:SKIN) received new United States Food and Drug Administration clearance for its specialized SkinStylus SteriLock MicroSystem to improve the appearance of periorbital wrinkles in adult patients.

Axsome Therapeutics (NASDAQ:AXSM) announced it dosed the first patient in its Phase 3 FOCUS-2 clinical trial evaluating solriamfetol as a potential treatment for children with attention deficit hyperactivity disorder.

Amazon.com (NASDAQ:AMZN) is looking to raise at least $25 billion through a U.S. dollar bond sale, according to Bloomberg News, as the company continues funding AI infrastructure investments.

Tvardi Therapeutics (NASDAQ:TVRD) reported Phase 1 data for TTI-109, a phosphate prodrug of STAT3 inhibitor TTI-101, including up to 60% reductions in STAT3-driven Th17, Tfh, and B cell populations.

Walmart (NASDAQ:WMT) announced extensive price rollbacks on seasonal food items, including ground beef, sodas, and fresh produce to help consumers combat persistent grocery inflation pressures.

Lumen Technologies (NYSE:LUMN) completed its $475 million acquisition of Alkira, an on-demand networking platform that helps enterprises connect clouds, sites, partners, and AI workloads.

Samsung Electronics fell 6.92% in South Korea after forecasting a 19-fold jump in second-quarter operating profit to ₩89.4 trillion, pressuring chip stocks across global markets.

Kailera Therapeutics (NASDAQ:KLRA) reported topline data from two Jiangsu Hengrui Pharmaceuticals Phase 3 trials of oral GLP-1 agonist HRS-7535/KAI-7535 in China, including mean weight loss of up to 11.1%.

Arthur J Gallagher (NYSE:AJG) announced it has acquired retail insurance broker Wilson M Beck Insurance Services to expand its commercial service footprint across Western Canada.

Klarna (NYSE:KLAR) announced a long-term commercial partnership with Southwest Airlines (NYSE:LUV) to bring flexible, transparent digital payment choices to domestic travelers.

Garmin (NYSE:GRMN) introduced its LiveScope 2 Series, a next-generation live-scanning sonar system designed for anglers with updated transducer technology and improved imaging performance.

Clearmind (NASDAQ:CMND) reported successful formulation-feasibility results for intranasal delivery of MEAI, its lead candidate initially aimed at treating alcohol use disorder.

Vivani Medical (NASDAQ:VANI) signed a new agreement with Novo Nordisk (NYSE:NVO) for a non-exclusive internal evaluation of NPM-139, its semaglutide implant for chronic weight management.

Digi Power X (NASDAQ:DGXX) reported progress across its Alabama AI data center campus, with Phase 1 still targeted for December 2026 and Phase 2 targeted for Q1 2027.

Aris Mining (NYSE:ARIS) produced 148 koz of gold in H1 2026, up 31% from H1 2025, while sales of 147.0 koz generated more than $680 million in revenue.

Palladyne (NASDAQ:PDYN) executed a previously announced contract from the Air Force Research Laboratory (AFRL) to develop technology that enables autonomous defense systems to operate as a coordinated network.

Zoetis (NYSE:ZTS) announced that the European Commission (EC) granted marketing authorization for Poulvac Procerta HVT-ND, a recombinant vector vaccine designed to protect chickens against Newcastle disease (ND) and Marek’s disease.

Gilat Satellite Networks (NASDAQ:GILT) announced that its Gilat DataPath subsidiary received approximately $11 million in orders from the U.S. Department of War for field services and customized SATCOM terminals.

UniTek Global Services acquired Concurrent Utility Services, a specialty infrastructure services company focused on power grid modernization and connectivity, to expand its Power Services Division.

Miami International Holdings (NYSE:MIAX) reported June 2026 trading metrics showing higher activity across its options exchanges, with U.S. multi-list options year-to-date average daily volume reaching 10.9 million contracts.

Compass Pathways (NASDAQ:CMPS) announced Phase 3 clinical trial results demonstrating that its proprietary synthetic psilocybin compound, COMP360, provides durable therapeutic relief for treatment-resistant depression.

Equifax (NYSE:EFX) agreed to acquire Círculo de Crédito, a Mexico-based credit bureau, in a transaction valued at an enterprise value of $750 million and a purchase price of $825 million.